|
Name |
Cryptoechinuline A
|
Molecular Formula | C24H27N3O2 | |
IUPAC Name* |
(3Z)-3-[[2-(2-methylbut-3-en-2-yl)-6-(3-methylbut-2-enyl)-1H-indol-3-yl]methylidene]-6-methylidenepiperazine-2,5-dione
|
|
SMILES |
CC(=CCC1=CC2=C(C=C1)C(=C(N2)C(C)(C)C=C)/C=C\3/C(=O)NC(=C)C(=O)N3)C
|
|
InChI |
InChI=1S/C24H27N3O2/c1-7-24(5,6)21-18(13-20-23(29)25-15(4)22(28)27-20)17-11-10-16(9-8-14(2)3)12-19(17)26-21/h7-8,10-13,26H,1,4,9H2,2-3,5-6H3,(H,25,29)(H,27,28)/b20-13-
|
|
InChIKey |
WXWNIBJUIDHOOC-MOSHPQCFSA-N
|
|
Synonyms |
Neoechinulin C; Cryptoechinuline A; Neoechinuline C; Cryptoechinulin-a; Cryptoechinulin A; 55179-54-9; X3GI5U3718; Alkaloid E 8, from aspergillus amstelodami; (3Z)-3-((2-(1,1-Dimethyl-2-propen-1-yl)-6-(3-methyl-2-buten-1-yl)-1H-indol-3-yl)methylene)-6-methylene-2,5-piperazinedione; 2,5-Piperazinedione, 3-((2-(1,1-dimethyl-2-propen-1-yl)-6-(3-methyl-2-buten-1-yl)-1H-indol-3-yl)methylene)-6-methylene-, (3Z)-; UNII-X3GI5U3718; HY-N10283; CS-0373510; Q27896934
|
|
CAS | 55179-54-9 | |
PubChem CID | 23425628 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 389.5 | ALogp: | 5.5 |
HBD: | 3 | HBA: | 2 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 74.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 29 | QED Weighted: | 0.583 |
Caco-2 Permeability: | -5.484 | MDCK Permeability: | 0.00001100 |
Pgp-inhibitor: | 0.402 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.03 | 20% Bioavailability (F20%): | 0.965 |
30% Bioavailability (F30%): | 0.039 |
Blood-Brain-Barrier Penetration (BBB): | 0.08 | Plasma Protein Binding (PPB): | 92.73% |
Volume Distribution (VD): | 0.725 | Fu: | 2.01% |
CYP1A2-inhibitor: | 0.949 | CYP1A2-substrate: | 0.543 |
CYP2C19-inhibitor: | 0.879 | CYP2C19-substrate: | 0.058 |
CYP2C9-inhibitor: | 0.852 | CYP2C9-substrate: | 0.6 |
CYP2D6-inhibitor: | 0.622 | CYP2D6-substrate: | 0.451 |
CYP3A4-inhibitor: | 0.91 | CYP3A4-substrate: | 0.342 |
Clearance (CL): | 3.777 | Half-life (T1/2): | 0.365 |
hERG Blockers: | 0.187 | Human Hepatotoxicity (H-HT): | 0.754 |
Drug-inuced Liver Injury (DILI): | 0.974 | AMES Toxicity: | 0.079 |
Rat Oral Acute Toxicity: | 0.994 | Maximum Recommended Daily Dose: | 0.684 |
Skin Sensitization: | 0.235 | Carcinogencity: | 0.873 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.042 |
Respiratory Toxicity: | 0.986 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002446 | 0.667 | D0O6KE | 0.250 | ||||
ENC006144 | 0.663 | D0R0MW | 0.223 | ||||
ENC003865 | 0.630 | D0W7WC | 0.217 | ||||
ENC002630 | 0.596 | D0JO3U | 0.217 | ||||
ENC002068 | 0.505 | D0Q0PR | 0.207 | ||||
ENC002460 | 0.491 | D01PZD | 0.204 | ||||
ENC004457 | 0.449 | D01SHZ | 0.203 | ||||
ENC002939 | 0.448 | D0I1FQ | 0.194 | ||||
ENC006145 | 0.440 | D0F4ZY | 0.191 | ||||
ENC005569 | 0.422 | D04UTT | 0.189 |